RNA-Loaded Dendritic Cell Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of CP-461 in Patients With Advanced Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
BMS 247550 to Treat Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
- Status
- COMPLETED
- Phase
- N/A
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
- Status
- UNKNOWN
- Phase
- PHASE1
Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- Status
- RECRUITING
- Phase
- N/A